Bioequivalence and Bioavailability Forum

Dear colleagues,

following topics will be discussed at a public meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly Advisory Committee for Pharmaceutical Science) on 02 May 2007:

1. Receive an update from the Office of Generic Drugs (OGD) on the bioequivalence of highly variable drugs,
   
2. receive an update on and discuss general strategies within the OGD pertaining to the bioequivalence of narrow therapeutic index drug products, and
   
3. discuss and provide comments on the topic of alcohol-induced dose dumping.